KEYTRUDA® (pembrolizumab) Plus Paclitaxel With or Without Bevacizumab Significantly Improved Key Secondary Endpoint of Overall Survival (OS) Versus Paclit…

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from the final analysis of ...

A New Antibody Treatment For Breast Cancer

A one‑year course of T‑DM1 offers excellent cancer‑free survival for early HER2‑positive breast cancer, with far less nerve ...
European Medical Journal

Second-Line Pazopanib Yields Positive Responses in Angiosarcomas

Pazopanib produced responses and acceptable safety in paclitaxel-pretreated angiosarcoma; read more about outcomes and ...
Phys.org

Advance in taxol biosynthesis could lead to large-scale production of anticancer drug

Paclitaxel is the world's best-selling plant-based anticancer drug and one of the most effective anticancer drugs over the past 30 years. It is widely used in the treatment of various types of cancer, ...
ascopubs.org

Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective Study

Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression The enrollment goal of 125 patients was met. Median age was 46 years (range, 21-65 years), ...
ascopubs.org

Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.

Second malignant neoplasms following treatment for Wilm's tumor: a report from the National Wilms' Tumor Study Group. Eligibility required measurable disease (stage IV or stage IIIB with malignant ...
The American Journal of Managed Care

Cost of Home vs Clinic Administration of Paclitaxel in Metastatic Breast Cancer

Home administration of oral paclitaxel and encequidar is associated with potential cost savings for payers compared with clinic administration of intravenous chemotherapy in metastatic breast cancer ...